NCT03874273 2019-03-14
Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 2/3 Unknown
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
University of Pittsburgh